WESTLAKE, Ohio, October 6, 2019 – Shares of Nordson Corporation (NASDAQ: NDSN) inclined 1.82% to $140.85. The stock traded total volume of 123.444K shares lower than the average volume of 168.76K shares.
For the quarter ended April 30, 2019, Nordson Corporation (NDSN) reported sales of $551.0M, which was a decrease of less than 1 percent contrast to the prior year’s second quarter sales of $554.0M. This change in second quarter 2019 sales included a boost of 3 percent organic volume, and a decrease related to the unfavorable effects of currency translation as contrast to the prior year’s second quarter of 4 percent. Growth in the quarter related to the first year effect of the fiscal 2018 acquisition of Clada Medical Devices was not significant.
In the second quarter of fiscal year 2019, reported operating profit was $129.0M, net income was $92.0M, and GAAP diluted earnings per share were $1.58, inclusive of a $0.04 per share discrete tax benefit related to share-based compensation. Prior year second quarter operating profit, net income and GAAP diluted earnings per share were $129.0M, $91.0M and $1.55, respectively.
Backlog for the quarter ended April 30, 2019 was $436.0M, a decrease of 2 percent contrast to the same period a year ago. Impact from the Clada Medical Devices acquisition in fiscal 2018 was not significant. Backlog amounts are calculated at April 30, 2019 exchange rates.
NDSN has the market capitalization of $8.12B and its EPS growth ratio for the past five years was 12.10%. The return on assets ratio of the Company was 9.30% while its return on investment ratio stands at 14.60%. Price to sales ratio was 3.73 while 71.80% of the stock was owned by institutional investors.